A phase II, randomized, double-blind study of the use of rucaparib versus placebo maintenance therapy in metastatic and recurrent endometrial cancer

IF 4.5 2区医学 Q1 OBSTETRICS & GYNECOLOGY

Gynecologic oncology Pub Date : 2024-10-09 DOI:10.1016/j.ygyno.2024.07.093

Bradley Corr , Ashley Haggerty , Stefan Gysler , Sarah Taylor , Kian Behbakht , Jill Alldredge , Carolyn Lefkowits , Lindsay Brubaker , Catherine Bouts , Lisa Marie Babayan , Samantha Hopp , Junxiao Hu , Saketh Guntupalli

引用次数: 0

查看原文本刊更多论文

针对转移性和复发性子宫内膜癌的鲁卡帕利与安慰剂维持疗法的II期随机双盲研究

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Gynecologic oncology 医学-妇产科学

CiteScore

8.60

自引率

6.40%

发文量

1062

审稿时长

37 days

期刊介绍： Gynecologic Oncology, an international journal, is devoted to the publication of clinical and investigative articles that concern tumors of the female reproductive tract. Investigations relating to the etiology, diagnosis, and treatment of female cancers, as well as research from any of the disciplines related to this field of interest, are published. Research Areas Include: • Cell and molecular biology • Chemotherapy • Cytology • Endocrinology • Epidemiology • Genetics • Gynecologic surgery • Immunology • Pathology • Radiotherapy